Skip to main content

Rocklage Scott M's Form 4 filing

Pear Therapeutics, Inc. (PEAR) · filed Nov 2, 2022

Accession no.
0001209191-22-055425
Filed
Nov 2, 2022, 7:49 PM ET
Trade date
Oct 31-Nov 2, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $150.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rocklage Scott MCIK 000121901410% Owner
Diekman John DCIK 000124035710% Owner
5AM Partners IV, LLCCIK 000158931410% Owner
5AM Ventures IV, L.P.CIK 000158931510% Owner
5AM Co-Investors IV, L.P.CIK 000159336110% Owner
Schwab Andrew J.CIK 000159854910% Owner
5AM Opportunities I, L.P.CIK 000175300010% Owner
5AM Opportunities I (GP), LLCCIK 000179077810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 31, 2022Class A Common StockSSaleDisposed−40,477$2.78−$112,526.0612,949,122Indirect
Oct 31, 2022Class A Common StockSSaleDisposed−1,687$2.78−$4,689.86539,548Indirect
Nov 1, 2022Class A Common StockSSaleDisposed−1,408$2.80−$3,942.412,947,714Indirect
Nov 1, 2022Class A Common StockSSaleDisposed−59$2.80−$165.2539,489Indirect
Nov 2, 2022Class A Common StockSSaleDisposed−10,155$2.72−$27,621.612,937,559Indirect
Nov 2, 2022Class A Common StockSSaleDisposed−423$2.72−$1,150.56539,066Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)